[1] 何文, 陈林俊, 刘真文, 等.抗精神病药所致高泌乳素血症的临床分析[J].实验与检验医学, 2014, 32(4):436.
[2] NAONO-NAGATOMO K, NAONO H, ABE H, et al.Partial regimen replacement with aripiprazole reduces serum prolactin in patients with a long history of schizophrenia:a case series[J].Asian J Psychiatr, 2017, 25:36.
[3] HOLT RI, PEVELER RC.Antipsychotics and hyperprolactinaemia:mechanisms, consequences and management[J].Clin Endocrinol, 2010, 74(2):141.
[4] 杨艳, 夏泳, 朱长江, 等.阿立哌唑对氨磺必利所致高泌乳素血症的影响研究[J].中国临床药理学与治疗学, 2016, 21(6):693.
[5] 何燕玲, 张明园.阳性和阴性综合征量表(PANSS)及其应用[J].临床精神医学杂志, 1997, 7(6):353.
[6] 张明园.精神科评定量表手册[M].2版.长沙:湖南科学技术出版社, 1998.
[7] 金建烽, 巢亚琴, 徐乐平, 等.合并小剂量阿立哌唑改善氯丙嗪所致高催乳素血症的临床研究[J].精神医学杂志, 2008(6):455.
[8] ANGELIKA W.Hyperprolactinemia caused by antipsychotic drugs[J].Br Medicl J, 2002, 24:250.
[9] PEUSKENS J, PANI L, DETRAUX J, et al.The effects of novel and newly approved antipsychotics on serum prolactin levels:a comprehensive review[J].CNS Drugs, 2014, 28(5):421.
[10] PEVELER RC, BRANFORD D, CITROME L, et al.Antipsychotics and hyperprolactinaemia:clinical recommendations[J].J Psychopharmacol, 2008, 22(Suppl2):98.
[11] 郭金宏, 曹长安, 廖春平, 等.阿立哌唑治疗抗精神病药物所致高催乳素血症[J].中国健康心理学杂志, 2013, 21(4):487.
[12] QIAO Y, YANG F, LI C, et al.Add-on effects of a low-dose aripiprazole in resolving hyperprolactinemia induced by risperidone or paliperidone[J].Psychiatr Res, 2016, 237:83.
[13] 王厚亮, 张俊成, 温盛霖, 等.不同剂量阿立哌唑对二代抗精神病药物致高泌乳素血症病人的添加治疗研究[J].中华神经医学杂志, 2014, 13(10):1035.
[14] 孟美玲, 李伟, 张少伟, 等.用阿立哌唑治疗以减轻其他抗精神病药物所致的高泌乳素血症:现有随机对照研究的meta分析[J].上海精神医学, 2015, 27(1):4.
[15] 汪正华, 阚博, 周恒.阿立哌唑对抗精神病药物所致高泌乳素血症的影响[J].皖南医学院学报, 2017, 36(2):143.
[16] GRUNDER G, CARLSSON A, WONG DF.Mechanism of new antipsychotic medications:occupancy is not just antagonism[J].Arch Gen Psychiatr, 2003, 60(10):974.
[17] DE BERARDIS D, FORNARO M, SERRONI N, et al.Treatment of antipsychotic-induced hyperprolactinemia:an update on the role of the dopaminergic receptors D2 partial agonist aripiprazole[J].Recent Pat Endocr Metab Immun Drug Discov, 2014, 8(1):30.
[18] SPAMHATT A.A systematic review of atipiprazole-dose, plasma concentration, receptor occupancy, and response:imphcations for therapeutic drug monitoring[J].J Clin Psychiatr, 2010, 71(11):1447.